Walk into a salt room in 2026 and you may hear claims that range from cautious to wild. The trade group counts more than 1,000 U.S. salt rooms. The science has not kept up. Most rooms cite the same handful of studies, often small, often unblinded, often funded by industry. This guide ranks 10 common halotherapy claims by evidence strength so you can decide if a session is worth your time and money.
A note on tiers. "Strong" means RCTs or a Cochrane review with consistent positive results. "Moderate" means a few small trials with mixed findings.
"Weak" means single pilot studies or observational data. "Anecdotal" means marketing material with no peer-reviewed support.
The FDA has not approved halotherapy for any medical condition. Per the American Lung Association statement on halotherapy (2026), no major pulmonary society backs it for asthma or allergic rhinitis.
| Rank | Claim | Evidence Tier | Cochrane Position | Verdict |
|---|---|---|---|---|
| 1 | Cystic fibrosis | Strong (saline only) | Supports nebulized hypertonic saline | Use medical nebulizer, not salt cave |
| 2 | Eczema / Atopic dermatitis | Moderate | No dedicated review | Adjunct may help, results modest |
| 3 | Bronchitis recovery | Moderate | Limited data | Possible symptom relief |
| 4 | COPD adjunctive | Weak | Insufficient evidence | One RCT, cannot recommend |
| 5 | Sinusitis | Weak | Saline rinses help, salt rooms unproven | Saline irrigation has better data |
| 6 | Allergies (seasonal) | Weak | No supporting review | Mechanism does not match IgE biology |
| 7 | Asthma symptom relief | Weak | "Too poorly designed" | Risk of bronchospasm |
| 8 | Stress / Relaxation | Anecdotal | None | Plausible but unstudied as halotherapy |
| 9 | Sleep improvement | Anecdotal | None | No controlled trials |
| 10 | Immune support | Anecdotal | None | Marketing claim, no mechanism |
1. Cystic Fibrosis: Strongest Evidence, but Wrong Delivery System
Cystic fibrosis is the only condition where salt has earned a Cochrane endorsement. Even that comes with a footnote. A 2023 Cochrane review by Wark and McDonald found nebulized hypertonic saline (3% or higher) improves mucociliary clearance and lung function in CF patients.
The benefit is most evident during acute exacerbations. The mechanism is direct: hypertonic saline pulls water into airway surface fluid and thins mucus, per a 2022 review of CF saline studies (2022).
The catch is delivery. Medical nebulizers produce particles of controlled size at known concentration aimed straight into the airway.
A halotherapy chamber spits variable salt dust into a room. Most particles land on the floor or your clothing. No published RCT shows salt cave sessions match nebulized saline for CF outcomes.
GRADE certainty for the Cochrane outcomes was rated "very low to low" in the 2023 review. Even the gold-standard study has weak supporting evidence. Verdict: Strong evidence for nebulized saline; salt caves remain unproven for CF.
2. Eczema and Atopic Dermatitis: Moderate, Mostly From Dead Sea Data
Skin claims have more support than most respiratory ones. Much of it comes from Dead Sea balneotherapy rather than dry salt aerosols.
A 2005 trial of Dead Sea salt baths (2005) showed improved hydration and reduced inflammation in atopic dermatitis patients. A pediatric speleotherapy study tracked 78% positive response in children with eczema after 24 months of cave treatment, per a 2024 review on salt therapy and the integumentary system (2024).
But a 2026 ScienceDirect study on salt and keratinocytes (2026) flagged a counter-signal. High-salt microenvironments may activate the SGK-1/mTOR pathway in keratinocytes and worsen atopic dermatitis progression. So salt cuts both ways.
Best candidates are adults with mild eczema willing to try halotherapy as an adjunct to standard moisturizers and topical steroids. People with broken or severely inflamed skin should skip it. Verdict: Moderate evidence for skin benefit, but Dead Sea data does not transfer cleanly to dry salt rooms.
3. Bronchitis Recovery: Small Trials, Promising Signals
Chronic bronchitis is where halotherapy has its longest history. The roots go back to Soviet-era speleotherapy in Eastern European salt mines.
A 2014 review in the International Journal of COPD (2014) summarized older trials. Results showed improved sputum clearance and reduced cough frequency after 10 to 20 sessions.
The trials were small, often unblinded, and rarely used standardized outcome measures. A 2021 comprehensive review in PMC (2021) noted salt aerosol may reduce airway inflammation and improve mucus rheology — plausible mechanisms even if the trials are weak.
Patients recovering from acute bronchitis sometimes report easier breathing after sessions. This may reflect the same osmotic effect that helps CF. Verdict: Moderate evidence for symptom relief, no proof of disease modification.
4. COPD Adjunctive Therapy: One RCT Is Not Enough
The COPD evidence base is thin. A 2014 systematic review in Dovepress (2014) searched Cochrane CENTRAL, PubMed, MEDLINE, EMBASE, and CINAHL.
The search retrieved 151 articles and found exactly one randomized controlled trial that met inclusion criteria. The authors concluded recommendations for halotherapy in COPD "cannot be made at this point."
A 2024 open-label post-COVID study reported subjective improvements in breathlessness and cough after 10 cave sessions. There was no change in diffusing capacity, per the 2020 respiratory disease review (2020). Subjective gains without objective change usually signal placebo or relaxation.
The American College of Chest Physicians and American Thoracic Society have not endorsed halotherapy for COPD. Patients should not substitute it for inhalers, pulmonary rehab, or smoking cessation. Verdict: Weak evidence, no major pulmonary society recommends it.
5. Sinusitis: Saline Rinses Win, Salt Rooms Lose
For chronic sinusitis, the evidence strongly favors a different salt delivery: nasal saline irrigation. A 2018 Cochrane review of saline irrigation for allergic rhinitis (2018) pooled 14 studies with 747 participants. The team concluded isotonic saline rinses provide measurable benefit as adjunctive therapy.
Dry salt rooms do not deliver salt to the sinus cavities at meaningful concentrations. The particles that reach the upper airway are far below the dose used in nasal rinses.
Sinus drainage requires direct flushing. There is no controlled trial comparing salt rooms to neti pots for sinusitis outcomes, per the 2019 PMC analysis of saline irrigation (2019).
Anyone with chronic sinusitis would get more documented benefit from a $15 sinus rinse kit than from a $40 salt room session. Verdict: Weak evidence for halotherapy; saline irrigation has the data.
6. Seasonal Allergies: Mechanism Does Not Match the Disease
Allergy claims appear on nearly every salt room website. The biology does not support them.
Allergic rhinitis is driven by IgE-mediated immune responses to specific allergens such as pollen, dust mites, and pet dander. Per HeyAllergy's 2024 evidence check (2024), even if salt aerosol temporarily clears the nose, it does nothing to dampen the underlying immune overreaction.
A 2014 study did find anti-inflammatory responses in asthma and bronchitis patients after salt therapy. The transfer to seasonal allergies is unproven. No Cochrane review supports the claim.
Sessions may produce temporary relief through humidification or mucus thinning, similar to a hot shower. Patients with mild seasonal symptoms may find sessions pleasant. Those with severe allergies need antihistamines, intranasal steroids, or immunotherapy. Verdict: Weak evidence, no biological mechanism that fits allergy pathophysiology.
7. Asthma Symptom Relief: The Cochrane Verdict Is Damning
The Cochrane Collaboration reviewed available halotherapy trials for asthma. It judged them "too poorly designed to draw conclusions," as summarized by the American Lung Association statement (2026).
A 2017 pilot study in mild asthmatic children suggested possible benefit, per the 2021 comprehensive asthma review (2021). The sample was small and unblinded.
The risk side matters here. Concentrated salt aerosol can trigger bronchospasm in patients with hyperreactive airways.
The Asthma and Allergy Foundation of America statement (2023) does not recommend halotherapy. It warns symptoms could worsen in some patients.
Anyone with poorly controlled asthma, severe persistent asthma, or a history of exercise-induced bronchospasm should not try halotherapy without consulting a pulmonologist. Bring a rescue inhaler if you do. Verdict: Weak evidence with documented risk of harm.
8. Stress and Relaxation: Plausible, but Not "Halotherapy" Per Se
Sitting in a dim, quiet room for 45 minutes will lower cortisol in most people. That is not halotherapy, that is rest.
No published RCT has isolated the salt aerosol's contribution to stress reduction versus the room's lighting, temperature, and absence of phones.
Salt cave operators cite a 2006 study suggesting an antidepressant effect. The citation trail is thin. The study is not indexed in PubMed under standard terms.
A 2024 stress intervention meta-analysis in ScienceDirect (2024) catalogs effective cortisol-reducing interventions. Halotherapy does not appear in the list.
If you find salt rooms calming, that is a real and valid benefit. Just understand you are paying for the environment, not the salt. Verdict: Anecdotal evidence, no controlled trials separating salt from setting.
9. Sleep Improvement: No Controlled Data
Sleep claims often piggyback on stress claims. The argument runs: lower cortisol leads to better sleep.
The evidence is missing. No published RCTs measure sleep outcomes (sleep latency, total sleep time, REM percentage) after halotherapy versus a control.
Wellness sites cite serotonin and melatonin pathways. These mechanisms are not validated for dry salt aerosol exposure, per the 2022 review of effective sleep interventions (2022).
People with sleep apnea, restless legs syndrome, or chronic insomnia should pursue documented treatments such as CPAP, CBT-I, or medication review. If a salt room helps you wind down and that translates to better sleep that night, take the win. Do not expect halotherapy to fix a sleep disorder. Verdict: Anecdotal evidence, no peer-reviewed sleep outcome data.
10. Immune Support: The Catch-All Marketing Claim
"Boosts immune system" sits on most salt room websites and almost no scientific papers. The phrase is vague enough to be unfalsifiable.
Per Healthline's 2024 halotherapy review (2024), there is no clinical mechanism by which inhaled salt particles would broadly enhance immune function.
Some operators point to anti-inflammatory or antibacterial properties of salt. Salt can inhibit bacterial growth at high concentrations on surfaces. Inhaled salt particles do not reach those concentrations in the airway, per Medical News Today's 2024 risk review (2024).
The American Lung Association and FDA have flagged COVID-related immune claims as unsupported and potentially deceptive. Anyone seeking immune support has better-documented options: sleep, exercise, vaccination, and balanced nutrition. Verdict: Anecdotal evidence, no biological mechanism, regulatory scrutiny on overreach.
How We Ranked
Our salt-cave / halotherapy rankings draw on:
- Verifiable studio attributes: halogenerator type and brand, salt grade, session length, and whether it's an active or passive cave (true active halotherapy requires a dry-salt aerosol generator, not just salt walls).
- Real-user signals: Google reviews from the past 24 months and respiratory-condition forums (asthma, COPD support groups) for outcome reports.
- First-hand visits where feasible, plus phone-script verification of halogenerator presence and operating cycle.
What we never accept: paid placement. Affiliate links to halogenerator brands appear on home/DIY pages, never on studio rankings.
Update cadence: quarterly studio re-verification. Email research@findsaltcave.com for corrections.
Frequently Asked Questions
Is halotherapy FDA approved for any medical condition? No. The FDA has not approved halotherapy for any medical claim. Salt rooms are wellness venues, not medical clinics, and operators face advertising restrictions on disease claims per SaltChamber's legal compliance guide.
What is the strongest evidence for any salt-based therapy? Nebulized hypertonic saline for cystic fibrosis, supported by a 2023 Cochrane review. This uses medical nebulizers with controlled particle size, not commercial salt rooms.
Can halotherapy hurt my asthma? It can. Concentrated salt aerosol may trigger bronchospasm in some asthmatics. The AAFA does not recommend halotherapy, and the American Lung Association warns symptoms may worsen.
How many sessions before I notice anything? Studies that report benefit usually use 10 to 20 sessions over 4 to 8 weeks. Many people notice nothing because the underlying evidence base is weak for most claims.
Is salt therapy safe during pregnancy or for kids? Most operators allow both, but no controlled safety data exists. Pregnant women and parents of young children should consult a clinician before sessions, especially if asthma is present.
Related Reading: Compare cost models in our salt cave membership pricing guide, check the long COVID respiratory evidence breakdown, or see who is a good candidate for salt caves and halotherapy.
-- The Salt Cave Finder Team